Angles 1

Jakub Tolar

Title: TBA
Date: Thursday 5 September 2024
Time: 14.30-15.00 CET

Bio

Jakub Tolar, MD, PhD is the dean of the University of Minnesota Medical School and a Distinguished McKnight University Professor in the Department of Pediatrics, Blood and Marrow Transplant & Cellular Therapy. He is also the vice president for Clinical Affairs at the University of Minnesota, board chair for University of Minnesota Physicians and co-leader of M Health Fairview, the joint clinical enterprise among the University of Minnesota Medical School, University of Minnesota Physicians and Fairview Health Services. An internationally recognized physician and researcher, Dr. Tolar is known for his care of patients with recessive dystrophic epidermolysis bullosa. His research is focused on developing cellular therapies for rare genetic disorders. Originally from the Czech Republic, Dr. Tolar received his medical education (MD) in Prague at Charles University. In 1992, he came to the University of Minnesota, where he received his PhD in Molecular, Cellular & Developmental Biology and Genetics.

Research Summary
Dr. Tolar’s research focuses on finding new ways to treat children with lethal, inherited diseases. He is also looking for safer and more effective gene therapy for diseases such as epidermolysis bullosa, mucopolysaccharidosis type I (Hurler syndrome), Fanconi anemia, and dyskeratosis congenita. Additional research interests include reducing the negative effects of stem cell transplantation (such as using mesenchymal stromal cells for graft-versus-host disease); creation and use of induced pluripotent stem cells; gene therapy using gene addition (with viral vectors and trasposons); and gene editing (with synthetic nucleases to repair genes).

Research Interests
Epidermolysis bullosa
Fanconi anemia
Dyskeratosis congenita
Hurler syndrome (MPS)
Gene therapy

Website: www.med.umn.edu/bio/jakub-tolar

Days
Hours

15% OFF

ESDR2024

More information coming soon